Post-approval studies (Phase 4)Active Not RecruitingNCT05864846
What this trial is testing
Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
Who this might be right for
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Jazz Pharmaceuticals 79